Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |